TP53 and breast cancer: To minimize their involvement and complications, we next compared our rat tumors induced by the two most common and potent oncogenic drivers in ER+ breast cancer, Pik3ca and Tp53 (Fig 2E) to the tumors in mice intraductally injected with AAV to edit the same two genes.